BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7388683)

  • 21. Destruction of highly purified cytochromes P-450 associated with metabolism of fluorinated ether anesthetics.
    Murphy MJ; Dunbar DA; Guengerich FP; Kaminsky LS
    Arch Biochem Biophys; 1981 Dec; 212(2):360-9. PubMed ID: 6798938
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoflurane: a comparison of its metabolism by human and rat hepatic cytochrome P-450.
    Bradshaw JJ; Ivanetich KM
    Anesth Analg; 1984 Sep; 63(9):805-13. PubMed ID: 6465574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
    Small DS; McNamara PJ
    Drug Metab Dispos; 1995 Apr; 23(4):465-72. PubMed ID: 7600913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of diamantane by rat liver microsomal cytochromes P-450.
    Hodek P; Janscák P; Anzenbacher P; Burkhard J; Janků J; Vodicka L
    Xenobiotica; 1988 Oct; 18(10):1109-18. PubMed ID: 3242307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species differences in cytochromes P-450 and epoxide hydrolase: comparisons of xenobiotic-induced hepatic microsomal polypeptides in hamsters and rats.
    Walz FG; Vlasuk GP; Steggles AW
    Biochemistry; 1983 Mar; 22(7):1547-56. PubMed ID: 6849865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of methyl-N-butyl ketone and phenobarbital on rat liver cytochromes P-450 and the metabolism of chloroform to phosgene.
    Branchflower RV; Schulick RD; George JW; Pohl LR
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):414-21. PubMed ID: 6658790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of promethazine and isosafrole on rat-hepatic microsomal mono-oxygenase activity: comparison with classic inducers phenobarbitone and beta-naphthoflavone.
    Taylor G; Houston JB; Elcombe CR
    Xenobiotica; 1985 Mar; 15(3):243-9. PubMed ID: 4024659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
    Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N
    J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
    Okita RT; Masters BS
    Drug Metab Dispos; 1980; 8(3):147-51. PubMed ID: 6104577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
    Malejka-Giganti D; Decker RW; Ritter CL
    Biochem Pharmacol; 1983 Nov; 32(22):3335-44. PubMed ID: 6316979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Naphthoflavone- and self-induced metabolism of 3,3',4,4'-tetrachlorobiphenyl in hepatic microsomes of the male, pregnant female and foetal rat.
    Morse DC; Van Bladeren PJ; Klasson Wehler E; Brouwer A
    Xenobiotica; 1995 Mar; 25(3):245-60. PubMed ID: 7618351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers.
    Crosbie SJ; Blain PG; Williams FM
    Hum Exp Toxicol; 1997 Mar; 16(3):131-7. PubMed ID: 9088965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered induction response of hepatic cytochrome P-450 to phenobarbital, 3-methylcholanthrene, and beta-naphthoflavone in organotin-treated animals.
    Rosenberg DW; Sardana MK; Kappas A
    Biochem Pharmacol; 1985 Apr; 34(7):997-1005. PubMed ID: 3986002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism by rat hepatic microsomes of fluorinated ether anesthetics following ethanol consumption.
    Rice SA; Dooley JR; Mazze RI
    Anesthesiology; 1983 Mar; 58(3):237-41. PubMed ID: 6829959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phenobarbital and beta-naphthoflavone on oxidative metabolism of N,N-dimethyl-4-aminoazobenzene by regenerating rat-liver microsomes and its response to sulphydryl compounds.
    Raza H; Levine WG
    Xenobiotica; 1986 Sep; 16(9):827-37. PubMed ID: 3094256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldrin epoxidation catalyzed by purified rat-liver cytochromes P-450 and P-448. High selectivity for cytochrome P-450.
    Wolff T; Greim H; Huang MT; Miwa GT; Lu AY
    Eur J Biochem; 1980 Oct; 111(2):545-51. PubMed ID: 6780342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
    Carlile DJ; Hakooz N; Houston JB
    Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine photolabels a substrate-binding site of rat hepatic cytochrome P-450 form PB-4.
    Frey AB; Kreibich G; Wadhera AB; Clarke L; Waxman DJ
    Biochemistry; 1986 Aug; 25(17):4797-803. PubMed ID: 3768313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.